Cysticidal treatment of neurocysticercosis, an infection of humans and pig brains with Taenia solium, results in an early inflammatory response directed to cysts causing seizures and focal neurological manifestations. Treatment-induced pericystic inflammation and its association with blood brain barrier (BBB) dysfunction, as determined by Evans blue (EB) extravasation, was studied in infected untreated and anthelmintic-treated pigs. We compared the magnitude and extent of the pericystic inflammation, presence of EB-stained capsules, the level of damage to the parasite, expression of genes for proinflammatory and regulatory cytokines, chemokines, and tissue remodeling by quantitative PCR assays between treated and untreated infected pigs and between EB-stained (blue) and non stained (clear) cysts. Inflammatory scores were higher in pericystic tissues from EB-stained cysts compared to clear cysts from untreated pigs and also from anthelmintic-treated pigs 48 hr and 120 hr after treatment. The degree of inflammation correlated with the severity of cyst wall damage and both increased significantly at 120 hours. Expression levels of the proinflammatory genes for IL-6, IFN-γ, TNF-α were higher in EB-stained cysts compared to clear cysts and unaffected brain tissues, and were generally highest at 120 hr. Additionally, expression of some markers of immunoregulatory activity (IL-10, IL-2Rα) were decreased in EB-stained capsules. An increase in other markers for regulatory T cells (CTLA4, FoxP3) was found, as well as significant increases in expression of two metalloproteases, MMP1 and MMP2 at 48 hr and 120 hr post-treatment. We conclude that the increase in severity of the inflammation caused by treatment is accompanied by both a proinflammatory and a complex regulatory response, largely limited to pericystic tissues with compromised vascular integrity. Because treatment induced inflammation occurs in porcine NCC similar to that in human cases, this model can be used to investigate mechanisms involved in host damaging inflammatory responses and agents or modalities that may control damaging post treatment inflammation To develop a better understanding of mechanisms of seizures and long-term epileptogenesis using neurocysticercosis, a workshop was held bringing together experts in epilepsy and epileptogenesis and neurocysticercosis. Human neurocysticercosis and parallel animal models offer a unique opportunity to understand basic mechanisms of seizures. Inflammatory responses to degenerating forms and later-stage calcified parasite granulomas are associated with seizures and epilepsy. Other mechanisms may also be involved in epileptogenesis. Naturally occurring brain infections with neurocysticercosis offer a unique opportunity to develop treatments for one of the world's most common causes of epilepsy and for the development of more general antiepileptogenic treatments. Key advantages stem from the time course in which an acute seizure heralds a start of the epileptogenic process, and radiographic changes of calcification and perilesional edema provide biomarkers of a chronic epileptic state

Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
Zip Code
Nash, Theodore E; Ware, JeanAnne M; Mahanty, Siddhartha (2017) Natural History of Patients With Perilesional Edema Around Taenia solium Calcified Granulomas. J Infect Dis 215:1141-1147
Nash, Theodore E; Bustos, Javier A; Garcia, Hector H et al. (2017) Disease Centered Around Calcified Taenia solium Granuloma. Trends Parasitol 33:65-73
Mahanty, Siddhartha; Orrego, Miguel A; Cangalaya, Carla et al. (2017) TNF-? blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis. PLoS Negl Trop Dis 11:e0006059
Del Brutto, O H; Nash, T E; White Jr, A C et al. (2017) Revised diagnostic criteria for neurocysticercosis. J Neurol Sci 372:202-210
Del Brutto, O H; Nash, T E; White Jr, A C et al. (2017) Revised set of diagnostic criteria for neurocysticercosis (in reply to Garg and Malhotra). J Neurol Sci 373:350-351
Cangalaya, Carla; Bustos, Javier A; Calcina, Juan et al. (2017) Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole. PLoS Negl Trop Dis 11:e0005624
Cangalaya, Carla; Bustos, Javier A; Calcina, Juan et al. (2016) Perilesional Inflammation in Neurocysticercosis - Relationship Between Contrast-Enhanced Magnetic Resonance Imaging, Evans Blue Staining and Histopathology in the Pig Model. PLoS Negl Trop Dis 10:e0004869
Williamson, Peter R; Nash, Theodore E; Williamson, Kim C et al. (2016) CNS infections in 2015: emerging catastrophic infections and new insights into neuroimmunological host damage. Lancet Neurol 15:17-9
Paredes, Adriana; Sáenz, Patricia; Marzal, Miguel W et al. (2016) Anti-Taenia solium monoclonal antibodies for the detection of parasite antigens in body fluids from patients with neurocysticercosis. Exp Parasitol 166:37-43
Ware, JeanAnne M; Nash, Theodore E (2016) The Lack of Association of Eosinophilia and Neurocysticercosis at Clinical Presentation: A Retrospective Analysis of Cases Seen at the National Institutes of Health, 1985-2015. Am J Trop Med Hyg 95:1432-1434

Showing the most recent 10 out of 35 publications